Physician profile
Peter D Berg
NPI 1780621730
$4,406.82
in general payments reported to CMS, 2019-2025
18 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,456 · 2020: $42.22 · 2021: $678 · 2022: $766 · 2023: $688 · 2024: $468 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $901.55 | 2019-2021 | |
| Oyster Point Pharma, INC. | $562.19 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $413.63 | 2019-2024 | Rocklatan |
| Sight Sciences, INC. | $393.27 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $346.86 | 2024-2025 | Xdemvy |
| Allergan, INC. | $247.84 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $223.86 | 2021-2025 | Cequa |
| New World Medical,INC. | $164.22 | 2019 | |
| Abbvie INC. | $152.59 | 2023-2025 | Lumigan |
| Glaukos Corporation | $144.37 | 2019 | |
| Shire North American Group INC | $142.58 | 2019 | |
| Amgen INC. | $142.29 | 2024-2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $134.16 | 2021-2024 | Acthar |
| Horizon Therapeutics Plc | $116.39 | 2019-2023 | Tepezza |
| Eyevance Pharmaceuticals LLC | $114.83 | 2019-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $98.38 | 2022-2025 | Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $85.31 | 2019-2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $22.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.